Drug recall · January 22, 2025
Diphenhydramine HCl 25 mg recall
Why: Labeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Diphenhydramine HCl 25 mg, 1000 Capsules per bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., 373 RT US 46 W Building E., Suite 117, Fairfield, NJ 07004, NDC 71399-8028-2.
- Lots / codes
Lot: KDC0124002B Exp 09/30/2026
- Quantity
- 456 bottles
- Company
- Akron Pharma, Inc., Fairfield, NJ
- Distribution
- Nationwide in the US
- Initiated
- December 12, 2024 · Voluntary: Firm initiated
- Classified
- January 10, 2025
- Reported
- January 22, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Diphenhydramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.